BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 679498)

  • 1. An improved method for the determination of human erythrocyte pyrimidine 5'-nucleotidase activity.
    Ellims PH; Bailey L; Van der Weyden MB
    Clin Chim Acta; 1978 Aug; 88(1):99-103. PubMed ID: 679498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A radioassay for pyrimidine-5'-nucleotidase activity.
    Buc H; Kaplan JC
    Clin Chim Acta; 1978 Apr; 85(2):193-6. PubMed ID: 647979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of human erythrocyte 5'-nucleotidases in healthy individuals and a patient deficient in pyrimidine 5'-nucleotidase.
    Swallow DM; Aziz I; Hopkinson DA; Miwa S
    Ann Hum Genet; 1983 Jan; 47(1):19-23. PubMed ID: 6301356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and properties of human erythrocyte pyrimidine 5'-nucleotidase.
    Torrance JD; Whittaker D; Beutler E
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3701-4. PubMed ID: 20631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of erythrocyte nucleotides in pyrimidine 5'-nucleotidase deficiency.
    Torrance JD; Whittaker D
    Br J Haematol; 1979 Nov; 43(3):423-34. PubMed ID: 497119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrimidine nucleotidase deficiency with active dephosphorylation of dTMP: evidence for existence of thymidine nucleotidase in human erythrocytes.
    Paglia DE; Valentine WN; Keitt AS; Brockway RA; Nakatani M
    Blood; 1983 Nov; 62(5):1147-9. PubMed ID: 6313098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some properties of human erythrocyte pyrimidine 5'-nucleotidase.
    Torrance JD; Whittaker DA
    Enzyme; 1981; 26(2):64-73. PubMed ID: 6263612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isozymes of human erythrocyte pyrimidine 5'-nucleotidase.
    Oda T; Nagao M; Shirono K; Kagimoto T; Takatsuki K
    J Lab Clin Med; 1985 Dec; 106(6):646-50. PubMed ID: 2999273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophoretic characterization of pyrimidine 5'-nucleotidase of human erythrocytes and its distinction from acid phosphatase.
    Rosa R; Valentin C; Rosa J
    Clin Chim Acta; 1977 Aug; 79(1):115-8. PubMed ID: 890945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of 5'-nucleotidase activity in human erythrocytes and plasma using high-performance liquid chromatography.
    Sakai T; Yanagihara S; Ushio K
    J Chromatogr; 1982 Apr; 239():717-21. PubMed ID: 6284776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrimidine nucleotidases from human erythrocyte possess phosphotransferase activities specific for pyrimidine nucleotides.
    Amici A; Emanuelli M; Magni G; Raffaelli N; Ruggieri S
    FEBS Lett; 1997 Dec; 419(2-3):263-7. PubMed ID: 9428647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrimidine-specific 5' nucleotidase activity in bovine erythrocytes: effect of phlebotomy and lead poisoning.
    George JW; Duncan JR
    Am J Vet Res; 1982 Jan; 43(1):17-20. PubMed ID: 6283951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple determination of erythrocyte pyrimidine 5'-nucleotidase activity in human blood by high-performance liquid chromatography.
    Tomokuni K; Ichiba M
    Ind Health; 1986; 24(4):227-33. PubMed ID: 3028992
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythrocyte arginase, pyrimidine 5'-nucleotidase (P5N), and deoxypyrimidine 5'-nucleotidase (dP5N) as indices of lead exposure.
    Cook LR; Angle CR; Stohs SJ
    Br J Ind Med; 1986 Jun; 43(6):387-90. PubMed ID: 3013277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPLC analysis of erythrocyte pyrimidine-5'-nucleotidase inhibition by lead.
    Rocco RM; Smart JL; Brown DR; Blumberg JB
    Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):127-36. PubMed ID: 6273981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay of human erythrocyte pyrimidine and deoxypyrimidine 5'-nucleotidase by isocratic reversed-phase high-performance liquid chromatography.
    Cook L; Schafer-Mitchell M; Angle C; Stohs S
    J Chromatogr; 1985 May; 339(2):293-301. PubMed ID: 2989306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrimidine nucleotides impair phosphoribosylpyrophosphate (PRPP) synthetase subunit aggregation by sequestering magnesium. A mechanism for the decreased PRPP synthetase activity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency.
    Lachant NA; Zerez CR; Tanaka KR
    Biochim Biophys Acta; 1989 Jan; 994(1):81-8. PubMed ID: 2535789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrimidine metabolism in hereditary erythrocyte pyrimidine 5' nucleotidase deficiency.
    Harley EH; Heaton A; Wicomb W
    Metabolism; 1978 Dec; 27(12):1743-54. PubMed ID: 723629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatographic analysis of human erythrocyte pyrimidine 5'-nucleotidase from five patients with pyrimidine 5'-nucleotidase deficiency.
    Hirono A; Fujii H; Natori H; Kurokawa I; Miwa S
    Br J Haematol; 1987 Jan; 65(1):35-41. PubMed ID: 3028466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte pyrimidine 5'-nucleotidase and deoxynucleotidase isozymes: metallosensitivity and kinetics.
    Cook L; Kubitschek C; Stohs S; Angle C
    Drug Chem Toxicol; 1988 Jun; 11(2):195-213. PubMed ID: 2841083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.